Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Dana-Farber Cancer Institute
NYU Langone Health
National Cancer Institute (NCI)
Children's Oncology Group
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
GOG Foundation
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Swiss Cancer Institute
Sarcoma Alliance for Research through Collaboration
Fred Hutchinson Cancer Center
Amgen